Patent ID: 7368475

Claim:
A method of treating an infection caused by herpesviridae or vaccinia virus in a mammalian subject in need thereof comprising administering to said subject an effective amount of at least one compound according to the formula wherein R 1 is selected from the group consisting of alkyl, aryl, O-aryl, S-aryl, OH, O-alkyl, SH, S-alkyl, NH 2 , N 3 , halogens, —OOCH, and COOH; wherein R 2 is selected from the group consisting of H, hydroxyl, aliphatic and aromatic ethers and esters; wherein R 3 is selected from the group consisting of alkyl, aryl, O-aryl, S-aryl, OH, O-alkyl, SH, S-alkyl, NH 2 , N 3 , halogens, —OOCH, COOH, siloxane rings, and acetal rings; and wherein R 4 is selected from the group consisting of alkyl, aryl, O-aryl, S-aryl, OH, O-alkyl, SH, S-alkyl, NH 2 , N 3 , halogens, —OOCH, COOH, siloxane rings, and acetal rings.